5 Recruiting Relapsed Or Refractory Multiple Myeloma Phase 1 Clinical Trials

Active phase 1 studies for relapsed or refractory multiple myeloma enrolling across the USA. Verify eligibility and contact site coordinators.

All Relapsed Or Refractory Multiple Myeloma studies

Phase 1 Studies for Relapsed Or Refractory Multiple Myeloma

🔵 Active, Not Recruiting Phase1

A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma

📍 Princess Margaret Hospital — Toronto, Ontario

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

📍 Research Site — Duarte, California

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma

📍 University of Alabama at Birmingham Hospital — Birmingham, Alabama

View Study & Checklist ➔

🟢 Recruiting Phase1

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

📍 Mayo Clinic Arizona — Phoenix, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase1

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

📍 City of Hope — Duarte, California

View Study & Checklist ➔